Masimo shareholders approve Danaher's acquisition

5 May 2026via Medical BuyerSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Masimo shareholders approve Danaher's acquisition. The deal, valued at $7.5 billion, has received unanimous approval from Masimo’s shareholders. This clears a key regulatory hurdle for Danaher to expand its healthcare portfolio. The acquisition is expected to close by mid-2024 pending final regulatory clearances.

📊 STOCKS: | 🏢 SECTOR: CapitalMarkets | #LOWIMPACT #Acquisition

#Acquisition#MedicalDevices#ShareholderApproval

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →